You are here

Bayer

Bayer cuts 1,500 jobs and lowers 2024 earnings guidance as Q1 sales dip

BioSpace

Tue, 05/14/24 - 11:52 am

Bayer confirms 2024 outlook despite slow start for agriculture, consumer health units

Reuters

Mon, 04/22/24 - 05:52 pm

consumer health

FDA fast-tracks AskBio’s heart failure gene therapy

Pharmaphorum

Thu, 04/18/24 - 11:14 am

3 patent expirations in 2024 and how companies are pivoting

Pharma Voice

Wed, 04/17/24 - 11:13 am

Bayer's patent for blood thinner Xarelto invalid, UK court rules

Reuters

Fri, 04/12/24 - 11:06 am

Bayer, Google partner on AI for time-pressed radiologists

Pharmaphorum

Wed, 04/10/24 - 09:21 am

artificial intelligence

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma Dive

Wed, 03/27/24 - 10:37 pm

Arch Venture Partners

More revamp at Bayer as it axes 90 at its U.S. headquarters in New Jersey

Fierce Pharma

Wed, 03/27/24 - 11:08 am

Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice

Fierce Pharma

Tue, 03/26/24 - 04:26 pm

Bristol Myers Squibb

Thermo Fisher, Bayer partner to develop companion diagnostics

BioPharma Dive

Thu, 03/21/24 - 11:33 am

Thermo Fisher Scientific

companion diagnostics

Bayer says 2024 sales of prostate cancer drug above $1 bln

Reuters

Thu, 03/21/24 - 10:58 am

prostate cancer

With executive shakeup and new pharma unit, Bayer's overhaul takes shape

Fierce Pharma

Wed, 03/20/24 - 09:44 pm

Bayer cues up filings for rival to Astellas’ menopause drug

Pharmaphorum

Tue, 03/19/24 - 11:35 am

Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial

Fierce Biotech

Tue, 03/19/24 - 11:21 am

neovascular age-related macular degeneration

Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets

BioSpace

Sun, 03/17/24 - 09:19 pm

artificial intelligence

drug development

Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO

BioPharma Dive

Thu, 03/7/24 - 11:13 am

Arch Venture Partners

Bayer CEO launches ‘full-scale effort’ to rejuvenate pharma pipeline, tables split-up but warns not never

Fierce Pharma

Tue, 03/5/24 - 11:37 am

Bayer pays $310M to buy into BridgeBio heart drug

BioPharma Dive

Mon, 03/4/24 - 11:52 am

transthyretin amyloidosis cardiomyopathy

Bayer wins FDA breakthrough therapy designation for NSCLC candidate

Clinical Trials Arena

Mon, 02/26/24 - 05:16 pm

breakthrough designation

non-small cell lung cancer

Another tough decision for Bayer as it plans to slash dividend by 95% to reduce debt

Fierce Pharma

Tue, 02/20/24 - 05:46 pm

Pages